Penumbra Inc (NYSE:PEN)
$ 318.57 +2.14 (+0.68%) Market Cap: 12.53 Bil Enterprise Value: 12.13 Bil PE Ratio: 73.40 PB Ratio: 8.50 GF Score: 89/100

Q3 2025 Penumbra Inc Earnings Call Transcript

Nov 5, 2025 / 09:30 PM GMT
Release Date Price: $225.54 (-4.06%)

Key Points

Positve
  • Penumbra Inc (PEN) reported a strong year-over-year revenue growth of 17.8% on a reported basis and 16.9% on a constant currency basis.
  • The company's US revenue increased by 21.5%, driven by significant growth in thrombectomy and embolization sales.
  • Penumbra Inc (PEN) achieved a gross margin expansion of 130 basis points, reaching 67.8%, with expectations to exceed 70% by the end of 2026.
  • The company successfully launched new products, Lightning Bolt 16 and Lightning Flash 3.0, enhancing its competitive position in the market.
  • Penumbra Inc (PEN) raised its revenue guidance for the year, reflecting confidence in continued growth and market expansion.
Negative
  • International revenue growth was modest at 6.6% year-over-year, with only a 3% increase in constant currency, partly due to ongoing challenges in China.
  • The neurovascular business faced a slight decline in the US stroke market, impacting overall growth in that segment.
  • Operating expenses increased, with SG&A expenses rising to 47.6% of revenue, reflecting investments in sales team expansion.
  • The company faces ongoing regulatory challenges, with the FDA review process for new products like Thunderbolt taking longer than anticipated.
  • Despite strong growth, the guidance for Q4 suggests a potential deceleration compared to previous quarters, raising concerns about sustaining momentum.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PEN.N - Penumbra Inc
Q3 2025 Penumbra Inc Earnings Call
Nov 05, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Gentlemen, good afternoon.

My name is Abby, your conference operator today.

At this time, I would like to welcome everyone to Penumbra's third quarter 2025 conference call.

All lines have been placed on mute to prevent any background noise.

After the speaker's remarks, there will be a question-and-answer session.

If you would like to ask a question during that time, simply pressar followed by the number one on your telephone keypad.

If you would like to withdraw your question, press 1 a second time.

Thank you, and I would now like to introduce Miss Cecilia Furlong, Business development and investor relations for Penumbra.

Miss.

Verloc, you may begin your conference
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot